Preliminary Program
Stream 1: Emerging Drug Targets
Session 101: New Targets Identification and Validation
Time: 08:30-12:00, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Dr. Kevin Liu, Head of Chemistry, Global Discovery Chemistry, Novartis Institute of Biomedical Research, China
Co-Chair: Call for Co-chair
Time |
FaceOn |
Speeches and Speakers |
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
|
Title: |
09:00-09:25 |
|
Dr. Kevin Liu, Head of Chemistry, Global Discovery Chemistry, Novartis Institute of Biomedical Research, China |
09:25-09:50 |
|
|
09:50-10:15 |
|
Title: |
10:15-10:30 |
Coffee Break |
Session 102: Protein Kinase and Phosphatases
Time: 08:30-12:00, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Time |
FaceOn |
Speeches and Speakers |
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
![]() |
Dr. David Augeri, Director of Molecular Design and Synthesis, RTS; Assoc. Professor, Dept. of Medicinal Chemistry, Rutgers University, USA |
09:00-09:25 |
|
Title: |
09:25-09:50 |
|
Title: |
09:50-10:15 |
|
Title: |
10:15-10:30 |
Coffee Break |
Session 103: G-protein Coupled Receptors(GPCR)& Ion-Channels
Time: 08:30-12:00, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Dr. Marco Falasca, Professor, Queen Mary University of London, UK
Co-Chair: Call for Co-chair
Time |
FaceOn |
Speeches and Speakers |
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
|
Dr. Jeff Reaga, Scientific Director, Amgen, USA |
09:00-09:25 |
|
Dr. Marco Falasca, Professor, Queen Mary University of London, UK |
09:25-09:50 |
|
Title: |
09:50-10:15 |
|
Dr. Dilip K. Tosh, Scientist, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA |
10:15-10:30 |
Coffee Break |
Session 104: Nuclear Receptor & Nucleic Acids
Time: 13:30-17:30, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 105: PROTACs and Targeted Protein Degradation
Time: 13:30-17:30, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 106: Emerging Ubiquitin and Autophagy Targets
Time: 13:30-17:30, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 107: Emerging Cell and Cytokine Targets
Time: 08:30-12:00, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 108: PD1/ PD-L1 and CTLA-4
Time: 08:30-12:00, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 109: Protein-Protein Interactions
Time: 13:30-17:30, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Session 110: Targeting NASH
Time: 13:30-17:30, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair